FibroBiologics
(NASDAQ) FBLG
FibroBiologics Financials at a Glance
Market Cap
$4.78MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$18.68M
EPS (TTM)
-$7.39
P/E Ratio
-0.12
Dividend
$0.00
Beta (Volatility)
-0.08 (Low)
Dividend
$0.00
Beta (Volatility)
-0.08 (Low)
Price
$0.88
Volume
76,433.901
Open
$0.85
Price
$0.88
Volume
76,433.901
Open
$0.85
Previous Close
$0.92
Daily Range
$0.85 - $0.92
52-Week Range
$0.73 - $14.68
Estimated Earnings Date
Jul 30, 2026
Dividend
$0.00
Beta (Volatility)
-0.08 (Low)
Price
$0.88
Volume
76,433.901
Open
$0.85
Previous Close
$0.92
Daily Range
$0.85 - $0.92
52-Week Range
$0.73 - $14.68
Estimated Earnings Date
Jul 30, 2026
FBLG News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout FibroBiologics
Industry
Biotechnology
Sector
Health CareEmployees
15
CEO
Peter O'Heeron
Website
www.fibrobiologics.comHeadquarters
Houston, TX 77598, US
FBLG Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-767.07%
Return on Capital
-194.36%
Return on Assets
-314.58%
Earnings Yield
-8.33%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.78MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
5.21M
Volume
76.43K
Avg. Volume
238.79K
Financials (TTM)
Gross Profit
-$234.00K
Operating Income
-$17.19M
EBITDA
-$17.56M
Operating Cash Flow
-$15.48M
Capital Expenditure
-$219.00K
Free Cash Flow
-$15.70M
Cash & ST Invst.
$1.48M
Total Debt
$2.48M
FibroBiologics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$4.78MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$367.31K
N/A
Employees
13
N/A
Net Income
-$5.00M
-0.7%
EBITDA
-$4.76M
+1.0%
Quarterly Fundamentals
Total Cash
$1.48M
-82.9%
Total Debt
$2.48M
-65.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$1.51M
+74.5%
Short Term Debt
$969.00K
-84.5%
Return on Assets
-3.15%
N/A
Return on Invested Capital
-4.18%
N/A
Free Cash Flow
-$4.36M
+17.9%
Operating Cash Flow
-$4.36M
+17.3%